Search Results: Obesity (204)

In a concerning statistic emerging from Malaysia, almost 100,000 individuals succumbed prematurely to various non-communicable diseases (NCDs) in 2022, falling short of the national average life expectancy of 75 years.  The primary culprits behind these early deaths were heart and cerebrovascular diseases, along with pneumonia, underscoring a pressing health crisis in the country.

Recent study reveals semaglutide, used in Ozempic & Wegovy, shows no increased suicidal ideation risk, expanding understanding of its safety.

We look at the top 5 most popular medical news stories across Southeast Asia this week!  #1 – Indonesia starts…

Fatty liver disease, a widespread health concern, demands a multifaceted approach to prevention and management. In a recent forum, Dr Espinosa’s insights shed light on the intricate relationship between lifestyle choices, dietary habits, and the prevalence of this condition, emphasising the urgency of proactive measures.

Dr Goh shared that “The complications from both type 1 and type 2 diabetes have serious complications when they attack blood vessels. When this happens, it can cause microvascular heart diseases and lead to blindness, kidney failure, loss of sensations in the nerve and more. Macrovascular heart disease causes heart attack and stroke.

Type 1 diabetes usually has more complications and has a greater impact on reducing the lifespan. However, in both diseases, the life expectancy is reduced. Therefore, the patient is better off getting a reversal cure via metabolic surgery. 

Discover why stopping a weight loss drug can lead to weight regain, highlighting the complexities of long-term obesity management.

Explore the brain’s role in appetite control and its implications for weight-loss strategies, featuring UCSF’s recent breakthrough study.

Singapore has embraced a groundbreaking solution for obstructive sleep apnoea (OSA) – an implantable pulse generator.  This innovative device promises…

With the emergence and increasing popularity of glucagon-like peptide 1 (GLP-1) agonists for the treatment of obesity in recent years, it might be worth investigating if these agents are able to reduce the cardiovascular risks associated with overweight and obesity, especially since they have been shown to reduce risk of major adverse cardiovascular events in patients with type 2 diabetes who are at high cardiovascular risk.

Explore how Singapore’s Nutri-Grade labelling, effective end of 2023, revolutionises beverage choices, aiming to reduce sugar intake.